A closed culture system for the ex vivo transduction and expansion of human T lymphocytes

Journal of Hematotherapy and Stem Cell Research

Volumn 7, Issue 3, 1998, Pages 205-215

  Robinet, Eric ^a,f   Certoux, Jean Marie ^a   Ferrand, Christophe ^a   Maples, Phillip ^b   Hardwick, Allan ^b   Cahn, Jean Yves ^c   Reynolds, Craig W ^d   Jacob, Will ^e   Hervé, Patrick ^a   Tiberghien, Pierre ^a  

^a Laboratoire d'Immunologie   (France)

^b BAXTER HEALTHCARE CORPORATION   (United States)

^c UNIVERSITY HOSPITAL JEAN MINJOZ   (France)

^d NATIONAL CANCER INSTITUTE   (United States)

^e NOVARTIS PHARMA AG   (Switzerland)

^f Etablissement Transfus SF C   (France)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS VECTOR;

ARTICLE; GENE REPLICATION; GENETIC TRANSDUCTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; HUMAN CELL; IMMUNOREGULATION; PRIORITY JOURNAL; SAFETY; T LYMPHOCYTE ACTIVATION; TARGET CELL; VIRUS EXPRESSION;

EID: 0031862790     PISSN: 15258165     EISSN: None     Source Type: Journal    
DOI: 10.1089/scd.1.1998.7.205     Document Type: Article

References (11)

1. Sullivan, K.M. Graft-versus-host disease. In Bone Marrow Transplantation, eds. Forman, S.J., Blume, K.G. & Thomas, E.D. Blackwell Scientific, Oxford, 1994, p. 339.
2. Maraninchi, D., Blaise, D., Rio, B., et al. Impact of T-cell depletion on outcome of allogeneic bone marrow transplantation for standard risk leukemias. Lancet 2:175, 1987.
3. Horrowitz, M.M., Gale, R.P., Sondel, P.M., et al. Graft-versus-leukemia reactions after bone marrow transplantation. Blood 75:555, 1990.
4. Bowden, R.A. Infections in patients with graft-versus-host disease. In Graft-Versus-Host Disease: Immunology, Pathophysiology and Treatment. Hematology, eds. Burakoff, S.J., Deeg, H.J., Ferrara, J., et al. Marcel Dekker, Inc., New York, 12:525, 1990.
5. Tiberghien, P., Brion, A., Deconinck, E., et al. Use of donor T-lymphocytes expressing herpes simplex thymidine kinase in allogeneic bone marrow transplantation: A phase I-II study. Hum. Gene Ther. 8:615, 1997.
6. Tiberghien, P. Use of suicide genes in gene therapy. J. Leukocyte Biol. 56:203, 1994.
7. Tiberghien, P., Reynolds, C.W., Keller, J., et al. Ganciclovir treatment of herpes simplex thymidine kinase-transduced primary T-lymphocytes: An approach for specific in vivo donor T-cell depletion after bone marrow transplantation? Blood 84:1333, 1994.
8. Lander, M.A. & Chattopadhyay, S.K. A Mus dunni cell line that lacks sequences closely related to endogenous murine leukemia virus and can be infected by ecotropic, amphotropic, xenotropic and mink cell focus forming viruses. J. Virol. 52:695, 1984.
9. Haapala, D.K., Robey, W.G., Oroszalan, S.D., et al. Isolation from cats of an endogenous type C virus with a novel envelope glycoprotein. J. Virol. 53:827, 1985.
10. Merrouche, Y., Negrier, S., Bain, C., et al. Clinical application of retroviral gene transfer in oncology - Results of a French study with tumor-infiltrating lymphocytes transduced with the gene of resistance to neomycin. J. Clin. Oncol. 13:410, 1995.
11. Bonini, C., Ferrari, G., Verzeletti, S., et al. HSV-tk gene transfer into donor lymphocytes for control of allogeneic graft-versus-leukemia. Science 276:1719, 1997.